We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
AMN Healthcare
AMN
$1.3B
| $17.9M | 0.03% |
+165,622
| New | +$18.2M |
|
302
Thor Industries
THO
$3.98B
| $17.5M | 0.03% |
245,264
+103,215
| +73% | +$8.43M |
|
303
Werner Enterprises
WERN
$2.42B
| $17.4M | 0.03% |
461,444
+82,124
| +22% | +$3.35M |
|
304
StoneX
SNEX
$8.85B
| $17.4M | 0.03% |
1,044,414
+761,967
| +270% | +$13M |
|
305
FerroAtlántica
GSM
$617M
| $17.3M | 0.03% |
3,274,312
-363,412
| -10% | -$2.25M |
|
306
Universal Corp
UVV
$1.34B
| $17.1M | 0.03% |
365,099
-205,832
| -36% | -$10.8M |
|
307
Employers Holdings
EIG
$906M
| $16.9M | 0.02% |
469,292
-14,828
| -3% | -$582K |
|
308
Nelnet
NNI
$4.81B
| $16.9M | 0.02% |
208,140
-3,266
| -2% | -$284K |
|
309
Par Pacific Holdings
PARR
$3.94B
| $16.7M | 0.02% |
949,753
-355,904
| -27% | -$6.04M |
|
310
Carter's
CRI
$1.43B
| $16.4M | 0.02% |
249,630
-211,153
| -46% | -$16.2M |
|
|
DOOR
311
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $16.4M | 0.02% |
229,612
-5,915
| -3% | -$491K |
|
312
Ameris Bancorp
ABCB
$5.77B
| $16.2M | 0.02% |
354,334
-10,912
| -3% | -$500K |
|
313
ProPetro Holding
PUMP
$1.32B
| $15.9M | 0.02% |
1,852,535
-39,143
| -2% | -$350K |
|
314
Terex
TEX
$7.89B
| $15.8M | 0.02% |
503,291
+120,536
| +31% | +$3.94M |
|
315
Delek US
DK
$3.95B
| $15.7M | 0.02% |
568,344
-1,015,407
| -64% | -$26.8M |
|
|
COOP
316
DELISTED
Mr. Cooper
COOP
| $15.1M | 0.02% |
374,641
-25,017
| -6% | -$1.06M |
|
317
Unisys
UIS
$245M
| $15M | 0.02% |
1,923,244
+307,866
| +19% | +$3.29M |
|
318
LPL Financial
LPLA
$26.5B
| $14.9M | 0.02% |
66,739
-39,341
| -37% | -$8.37M |
|
319
Columbia Banking Systems
COLB
$8.74B
| $14.7M | 0.02% |
499,656
-35,469
| -7% | -$1.07M |
|
320
PennyMac Financial
PFSI
$4.39B
| $14.7M | 0.02% |
331,575
-163,604
| -33% | -$8.55M |
|
|
RCM
321
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.6M | 0.02% |
790,303
-689,654
| -47% | -$15.7M |
|
322
John Wiley & Sons Class A
WLY
$2.59B
| $14.4M | 0.02% |
+377,767
| New | +$17.9M |
|
323
Spectrum Brands
SPB
$2.04B
| $14.1M | 0.02% |
350,532
-92,893
| -21% | -$5.99M |
|
|
ACH
324
Accendra Health
ACH
$247M
| $14M | 0.02% |
+605,659
| New | +$18.7M |
|
325
AGCO
AGCO
$8.71B
| $13.9M | 0.02% |
141,358
+61,042
| +76% | +$6.35M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.